Dr Rachel Payne joined QCGC Research in September 2023 as a part-time Clinical Research Monitor working on the ENDO-3 study. Previously, she worked as a Clinical Research Associate for 6 years working in varied therapeutic areas such as Oncology, Neurology, Dermatology and Rare Diseases.

Rachel completed a PhD in Clinical Cancer Research from Imperial College London in 2011. She is passionate about working in research that improves the health outcomes and quality of life for women with Gynaecological Cancer.